• English
  • Español
  • CONTACT US
  • HOME
ONCOMATRYX

ONCOMATRYX

pioneering stromal medicine

Menu

  • ABOUT
    • TARGETING TUMOR STROMA
    • LEADERSHIP
    • SCIENTIFIC ADVISORY BOARD
    • COLLABORATIONS
    • PUBLICATIONS
  • DRUG DISCOVERY
    • PRECISION DRUGS
    • ANTIBODY DRUG CONJUGATES
      • ADC OMTX705
      • ADC OMTX703
    • PIPELINE
  • DIAGNOSTICS
    • COL11A1 BIOMARKER
    • INVASIVE TUMOR DIAGNOSTICS -invaScan-
    • BLADDER CANCER DIAGNOSTICS -bladderScan-
  • COMPANION DX
    • COMPANION DIAGNOSTICS
  • BLOG
    • TEAM POSTS
    • NEWS
    • PRESS Releases
    • VIDEO
  • CONTACT
    • CONTACT US
    • CAREERS
    • NEXT EVENT
TARGETING TUMOR STROMA

TARGETING TUMOR STROMA

novel precision drugs that target the tumor microenvironment

Read more
ANTIBODY DRUG CONJUGATES

ANTIBODY DRUG CONJUGATES

stroma-targeted ADCs to fight against invasive tumors

Read more
PIPELINE

PIPELINE

Read more

“I declare war on cancer stroma”

“I declare war on cancer stroma”

LAUREANO SIMON, Oncomatryx CEO, declares war on tumor microenvironment. “We envision a new era where cancer in general and invasive tumors in particular will be beaten with orchestrated combinations of precision

Oncomatryx2022-05-302022-03-09 VIDEO Read more

Clinical Trial

Clinical Trial

Published by Deia 2022 – 05 -23

OMTX2022-05-302022-05-30 PRESS Releases No Comments Read more

Oncomatryx Capital increase 2022

Oncomatryx Capital increase 2022

Published by EXPANSIÓN  2022-03-08 Oncomatryx has carried out a capital increase of 15 million euros to start clinical trials with people with invasive tumors in Spain and the USA.

OMTX2022-03-092022-03-15 PRESS Releases No Comments Read more

Bizkaia Impacto Social 2022 Award

Bizkaia Impacto Social 2022 Award

Published by El Correo 2022-03-07.  Oncomatryx Biopharma, S.L. has been honoured with the 2022 Bizkaia Social Impact Award (Premio Impacto Social 2022)  by BBK and EL CORREO at the Sustainable Competitiveness Awards

OMTX2022-03-072022-03-09 PRESS Releases No Comments Read more

PEGS Europe Virtual Summit 2020

PEGS Europe Virtual Summit 2020

12 Annual PEGS Europe Virtual Summit 2020 9 Nov – 12 Nov 2020 Myriam Fabre, PhD. (Oncomatryx R&D Director) will attend the virtual conference as a speaker on next Tuesday

OMTX2020-11-062020-11-06 NEWS No Comments Read more

Poster Presentation at ESMO 2018 Congress

Poster Presentation at ESMO 2018 Congress

ESMO 2018 Congress Munich, Germany – 19 Oct – 23 Oct 2018 Myriam Fabre, PhD. (Oncomatryx R&D Director) presents the poster: OMTX705, a powerful stroma-targeting ADC to treat invasive tumors with

Oncomatryx2018-10-032019-10-11 NEWS No Comments Read more

Oncomatryx at BIO EUROPE SPRING 2018

Oncomatryx at BIO EUROPE SPRING 2018

Oncomatryx will attend BIO EUROPE SPRING 2018, the essential appointment in biotechnology BIO EUROPE SPRING 2018 March 12-14, 2018 Amsterdam, The Netherlands https://ebdgroup.knect365.com/bioeurope- If you are also attending this event and you would like

Oncomatryx2018-02-012019-10-11 NEWS No Comments Read more

Oncomatryx at BIO 2017 (San Diego)

Oncomatryx at BIO 2017 (San Diego)

Oncomatryx will attend BIO 2017, the Global Event for Biotechnology.  

Oncomatryx2017-04-282019-10-11 NEWS No Comments Read more

Oncomatryx events in March

Oncomatryx events in March

ENTURE SUMMIT WEST 2017 February 28 – March 1 2017 Mountain View, CA USA David Raksin, our Business Development Director will be a Presenting role as a Top Innovator in

Oncomatryx2017-02-102019-10-11 NEWS No Comments Read more

Antibody Drug Conjugates, the beginning of the end?

Antibody Drug Conjugates, the beginning of the end?

  Antibody Drug Conjugates Against Tumor Stroma: The Beginning of The End? by Mirella Zulueta, Business Development Director at Oncomatryx   The potential of a technology trigger Despite many research breakthroughs

Oncomatryx2016-11-122019-10-11 TEAM POSTS No Comments Read more
  • « Previous
  • TEAM POSTS
  • NEWS
  • PRESS Releases
  • VIDEO
Suscribe our cancer stroma newsletter and stay updated in precision medicine, with new releases, events, news and more.

Tags

pancreas simon stroma tumor war on cancer

Archives

PRECISION DRUGS

  • PRECISION DRUGS
  • ANTIBODY DRUG CONJUGATES
  • PIPELINE

DIAGNOSTICS

  • COL11A1 BIOMARKER
  • INVASIVE TUMOR DIAGNOSTICS -invaScan-
  • BLADDER CANCER DIAGNOSTICS -bladderScan-

With the collaboration of:

ONCOMATRYX BIOPHARMA SL ©2019
  • English
  • Español
  • TERMS OF USE
  • PRIVACY POLICY
  • SITE MAP